Zhejiang Kaier New Materials (300234.SZ)'s controlling shareholder and its concert parties plan to transfer 10.3% of the company's shares to Luzhou Jinkai.
Zhejiang Kaier New Materials (300234.SZ) announced that its controlling shareholder and its concert parties, Mr. Xing Hanxue, Ms. Wu Jianming, and Mr. Xing Hanke, signed a Share Transfer Agreement on September 15, 2026 with Luzhou Jinkai Innovation Investment Partnership (Limited Partnership) (referred to as "Luzhou Jinkai"), agreeing that the transferors would transfer a total of 51,826,600 unrestricted tradable shares of the company (accounting for 10.30% of the company's total share capital) to Luzhou Jinkai at a price of RMB 8.03 per share, with a total transfer price of approximately RMB 416 million (tax inclusive). After the completion of this agreement-based transfer, Luzhou Jinkai will hold 51,826,600 shares of the company, accounting for 10.30% of the company's total share capital, and will become a shareholder holding more than 5% of the company.
Zhejiang Kaier New Materials (300234.SZ) announced that the company's controlling shareholder and its concert parties, Mr. Xing Hanxue, Ms. Wu Jianming, and Mr. Xing Hanke, signed a Share Transfer Agreement with Luzhou Jinkai Innovation Investment Partnership (Limited Partnership) (referred to as "Luzhou Jinkai") on September 15, 2026, agreeing that the transferors would transfer a total of 51,826,600 unrestricted tradable shares of the company (accounting for 10.30% of the company's total share capital) to Luzhou Jinkai at a price of RMB 8.03 per share, with a total transfer price of approximately RMB 416 million (tax inclusive). After the completion of this agreement-based transfer, Luzhou Jinkai will hold 51,826,600 shares of the company, accounting for 10.30% of the company's total share capital, and will become a shareholder holding more than 5% of the company.
Related Articles

SR MEDICAL (00108): Shao Jiyou nominated as executive director

HOMELAND ITL (03798) repurchased 20,000 shares for HKD 25,800 on September 16.

Hongfucheng (301716.SZ): After the clawback, the online issuance subscription success rate is approximately 0.0141%.
SR MEDICAL (00108): Shao Jiyou nominated as executive director

HOMELAND ITL (03798) repurchased 20,000 shares for HKD 25,800 on September 16.

Hongfucheng (301716.SZ): After the clawback, the online issuance subscription success rate is approximately 0.0141%.

RECOMMEND





